WallStreetZenWallStreetZen

NASDAQ: OVID
Ovid Therapeutics Inc Stock Ownership - Who owns Ovid Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ovid Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin Joseph FitzgeraldDirector2026-04-0717,578$2.56
$45.00kBuy
Bart FriedmanDirector2026-04-078,789$2.56
$22.50kBuy
Stelios PapadopoulosDirector2026-04-0717,578$2.56
$45.00kBuy
Jeremy M. LevinExecutive Chairman2026-03-2347,333$1.40
$66.27kBuy
Margaret A. AlexanderPresident and CEO2026-02-2311,656$1.45
$16.90kSell
Jeffrey A. RonaCBFO2026-02-238,541$1.45
$12.38kSell

1 of 1

OVID insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OVID insiders and whales buy or sell their stock.

OVID Shareholders

What type of owners hold Ovid Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP8.12%10,714,000$29.89MInstitution
Takeda Pharmaceutical Co Ltd6.66%8,781,996$24.50MInsider
Affinity Asset Advisors LLC5.42%7,150,000$19.95MInstitution
Matthew During3.62%4,772,429$13.32MInsider
Adar1 Capital Management LLC3.25%4,285,000$11.96MInstitution
Eventide Asset Management LLC3.25%4,285,000$11.96MInstitution
Jeremy M. Levin2.86%3,770,509$10.52MInsider
Federated Hermes Inc2.71%3,571,000$9.96MInstitution
Point72 Asset Management LP2.69%3,551,129$9.91MInstitution
Adage Capital Partners GP LLC2.65%3,492,000$9.74MInstitution

1 of 3

OVID vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OVID46.85%14.10%Net BuyingNet Buying
ALT42.17%48.80%Net BuyingNet Buying
IRD8.23%91.77%Net SellingNet Selling
AKBA44.14%8.15%Net SellingNet Buying
MNPR22.50%77.50%Net SellingNet Selling
View Top Biotech Stocks

Ovid Therapeutics Stock Ownership FAQ

Who owns Ovid Therapeutics?

Ovid Therapeutics (NASDAQ: OVID) is owned by 46.85% institutional shareholders, 14.10% Ovid Therapeutics insiders, and 39.05% retail investors. Takeda Pharmaceutical Co Ltd is the largest individual Ovid Therapeutics shareholder, owning 8.78M shares representing 6.66% of the company. Takeda Pharmaceutical Co Ltd's Ovid Therapeutics shares are currently valued at $24.50M.

If you're new to stock investing, here's how to buy Ovid Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.